Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms

Current Opinion in Urology

Volumn 21, Issue 1, 2011, Pages 1-4

  Parsons, J K ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

benign prostatic hyperplasia; diabetes; exercise; lower urinary tract symptoms; obesity

Indexed keywords

ATORVASTATIN; LIPID; LIPOPROTEIN;

ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; DIABETES MELLITUS; EXERCISE; FAT INTAKE; GLYCEMIC CONTROL; HUMAN; LIFESTYLE; LOWER URINARY TRACT SYMPTOM; MEAT; METABOLISM; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RISK ASSESSMENT;

ALGORITHMS; HUMANS; LIFE STYLE; MALE; PROSTATIC HYPERPLASIA; RISK FACTORS; UROLOGIC DISEASES;

EID: 78650511881     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32834100c9     Document Type: Article

References (30)

1. Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: New approaches to old problems. J UrolV 178 2007; 395-401.
2. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: Benign prostatic hyperplasia. J Urol 2005; 173:1256-1261.
3. Boyle P, Robertson C, Mazzetta C, et al. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int 2003; 92:409-414. (Pubitemid 37100519)
4. Kupelian V, Wei JT, O'Leary MP, et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: The Boston Area Community Health (BACH) Survey. Arch Intern Med 2006; 166:2381-2387.
5. Taylor BC, Wilt TJ, Fink HA, et al. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: The MrOS study. Urology 2006; 68:804-809.
6. Trueman P, Hood SC, Nayak US, Mrazek MF. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK. BJU Int 1999; 83:410-415.
7. Parsons JK, Bergstrom J, Silberstein J, Barrett-Connor E. Prevalence and characteristics of lower urinary tract symptoms in men aged > or =80 years. Urology 2008; 72:318-321.
8. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44:637-649.
9. Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab 2006; 91:2562-2568.
10. Parsons JK, Sarma AV, McVary K, Wei JT. Obesity and benign prostatic hyperplasia: Clinical connections, emerging etiological paradigms and future directions. J Urol 2009; 182 (Suppl 6):S27-S31. This comprehensive review of published studies concluded that obesity significantly increases the risks of BPH and LUTS.
11. Kristal AR, Arnold KB, Schenk JM, et al. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial. J Urol 2007; 177:1395-1400; quiz 591.
12. Seim A, Hoyo C, Ostbye T, Vatten L. The prevalence and correlates of urinary tract symptoms in Norwegian men: The HUNT study. BJU Int 2005; 96:88-92.
13. Rohrmann S, Smit E, Giovannucci E, Platz EA. Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2004; 159:390-397. (Pubitemid 38200773)
14. Nandeesha H, Koner BC, Dorairajan LN, Sen SK. Hyperinsulinemia and dyslipidemia in nondiabetic benign prostatic hyperplasia. Clin Chim Acta 2006; 370:89-93.
15. Parsons JK, Bergstrom J, Barrett-Connor E. Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men. BJU Int 2008; 101:313-318.
16. Rohrmann S, Smit E, Giovannucci E, Platz EA. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obes (Lond) 2005; 29:310-316. (Pubitemid 40333230)
17. Burke JP, Rhodes T, Jacobson DJ, et al. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia. Am J Epidemiol 2006; 164:41-46.
18. Sarma AV, Burke JP, Jacobson DJ, et al. Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men. Diabetes Care 2008; 31:476-482.
19. Burke JP, Jacobson DJ, McGree ME, et al. Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota. Urology 2006; 67:22-25.
20. Van Den Eeden SK, Sarma AV, Rutledge BN, et al. Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes Care 2009; 32:664-670.
21. Gupta A, Gupta S, Pavuk M, Roehrborn CG. Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: A prospective cohort study of Air Force veterans. Urology 2006; 68:1198-1205. (Pubitemid 44880381)
22. Sarma AV, Parsons JK, McVary K, Wei JT. Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms: What do we know? J Urol 2009; 182 (Suppl 6):S32-S37.
23. Kristal AR, Arnold KB, Schenk JM, et al. Dietary Patterns, Supplement Use, and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results from the Prostate Cancer Prevention Trial. Am J Epidemiol 2008; 167:925-934.
24. Parsons JK, Kashefi C. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol 2008; 53:1228-1235.
25. Parsons JK, Im R. Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia. J Urol 2009; 182:1463-1468.
26. Tavani A, Longoni E, Bosetti C, et al. Intake of selected micronutrients and the risk of surgically treated benign prostatic hyperplasia: A Case-Control Study from Italy. Eur Urol 2005. http://www.sciencedirect.com/and http://www.europeanurology.com/.
27. Rohrmann S, Smit E, Giovannucci E, Platz EA. Association between serum concentrations of micronutrients and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey. Urology 2004; 64:504-509. (Pubitemid 39200747)
28. Lekili M, Muezzinoglu T, Uyanik BS, Buyuksu C. Serum lipid levels in benign prostatic hyperplasia. World J Urol 2006; 24:210-213. (Pubitemid 43842553)
29. ZucchettoA,Tavani A,DalMasoL, et al.History of weightandobesity through life and risk of benign prostatic hyperplasia. Int J Obes (Lond) 2005; 29:798-803.
30. Mills IW, Crossland A, Patel A, Ramonas H. Atorvastatin Treatment for Men with Lower Urinary Tract Symptoms and Benign Prostatic Enlargement. Eur Urol 2007:503-509.